Microbot Medical, Inc. is a pre-clinical medical device company engaged in the research, design, development, and commercialization of micro-robotics assisted medical technologies. The company is headquartered in Hingham, Massachusetts and currently employs 21 full-time employees. The company has developed the single-use, fully disposable endovascular robotic system, which aims to eliminate traditional barriers to accessing advanced robotic systems. The company specializes in the research, design and development of robotic endoluminal surgery devices targeting the minimally invasive surgery space. Using its LIBERTY technological platform, it is developing a fully disposable robot for various endovascular interventional procedures. The LIBERTY Endovascular Robotic Surgical System is designed to maneuver guidewires and over-the-wire devices (such as microcatheters) within the body’s vasculature. The company eliminates the need for extensive capital equipment requiring dedicated Cath-lab rooms as well as dedicated staff. Its addressable markets for the LIBERTY Endovascular Robotic Surgical System include the peripheral interventional radiology, interventional cardiology and interventional neuroradiology markets.
최신 재무제표(Form-10K)에 따르면, Microbot Medical Inc의 총 자산은 $0이며, 순손실입니다.
MBOT의 주요 재무 비율은 무엇인가요?
Microbot Medical Inc의 유동비율은 0이고, 순이익률은 0, 주당 매출은 $0입니다.
Microbot Medical Inc의 매출은 부문 또는 지역별로 어떻게 나뉘나요?
Microbot Medical Inc 주요 수익원은 Other이며, 최신 수익 발표에서 수익은 14,872,000,000입니다. 지역별로는 Asia-Pacific (ex-Japan)이 Microbot Medical Inc의 주요 시장이며, 수익은 4,204,000,000입니다.
Microbot Medical Inc은 수익성이 있나요?
no, 최신 재무제표에 따르면 Microbot Medical Inc의 순손실은 $0입니다.